MindMaze SA announced $105m in new funding on 17 February, led by Concord Health Partners with participation from London-based Hambro Perks and AlbaCore Capital Group.
The financing will enable the Swiss “brain tech” startup to “accelerate its global commercial growth plans, supercharge ongoing R&D, and...